Blood biomarker for Parkinson disease: peptoids

Parkinson disease (PD) is the second most common neurodegenerative disease. Because dopaminergic neuronal loss begins years before motor symptoms appear, a biomarker for the early identification of the disease is critical for the study of putative neuroprotective therapies. Brain imaging of the nigr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazdani, Umar, Zaman, Sayed, Hynan, Linda S, Brown, L Steven, Dewey, Richard B, Karp, David, German, Dwight C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088434/
https://www.ncbi.nlm.nih.gov/pubmed/27812535
http://dx.doi.org/10.1038/npjparkd.2016.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088434/
https://www.ncbi.nlm.nih.gov/pubmed/27812535
http://dx.doi.org/10.1038/npjparkd.2016.12

Ejemplares similares